These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29020401)

  • 21. Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data.
    Wasfy JH; Price M; Normand ST; Januzzi JL; McCarthy CP; Hsu J
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009986. PubMed ID: 38240159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
    Lambrakis K; French JK; Scott IA; Briffa T; Brieger D; Farkouh ME; White H; Chuang AM; Tiver K; Quinn S; Kaambwa B; Horsfall M; Morton E; Chew DP
    Am Heart J; 2019 Feb; 208():11-20. PubMed ID: 30522086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.
    Vargas KG; Haller PM; Jäger B; Tscharre M; Binder RK; Mueller C; Lindahl B; Huber K
    Clin Res Cardiol; 2019 Jul; 108(7):749-762. PubMed ID: 30535801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 1 or Type 2 Myocardial Infarction in Patients with a History of Coronary Artery Disease: Data from the Emergency Department.
    Putot A; Jeanmichel M; Chagué F; Avondo A; Ray P; Manckoundia P; Zeller M; Cottin Y
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31810178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
    Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
    Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
    Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M
    Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.
    Lee WJ; Cheng H; Whitney BM; Nance RM; Britton SR; Jordahl K; Lindstrom S; Ruderman SA; Kitahata MM; Saag MS; Willig AL; Burkholder G; Eron JJ; Kovacic JC; Björkegren JLM; Mathews WC; Cachay E; Feinstein MJ; Budoff M; Hunt PW; Moore RD; Keruly J; McCaul ME; Chander G; Webel A; Mayer KH; Delaney JA; Crane PK; Martinez C; Crane HM; Hao K; Peter I
    Int J Cardiol; 2023 Jul; 383():15-23. PubMed ID: 37149004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes.
    Schulte C; Singh B; Theofilatos K; Sörensen NA; Lehmacher J; Hartikainen T; Haller PM; Westermann D; Zeller T; Blankenberg S; Neumann JT; Mayr M
    J Mol Cell Cardiol Plus; 2022 Sep; 1():None. PubMed ID: 36185590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.
    Nance RM; Crane HM; Ritchings C; Rosenblatt L; Budoff M; Heckbert SR; Drozd DR; Mathews WC; Geng E; Hunt PW; Feinstein MJ; Moore RD; Hsue P; Eron JJ; Burkholder GA; Rodriguez B; Mugavero MJ; Saag MS; Kitahata MM; Delaney JAC
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):916-921. PubMed ID: 29984593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of outcome among type 2 vs type 1 myocardial infarction: a systematic review and meta-analysis.
    Jaiswal V; Ang SP; Ishak A; Nasir YM; Chia JE; Naz S; Jaiswal A
    J Investig Med; 2023 Mar; 71(3):223-234. PubMed ID: 36705027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association of Electrocardiographic Abnormalities and Acute Coronary Syndrome in Emergency Patients With Chest Pain.
    Knowlman T; Greenslade JH; Parsonage W; Hawkins T; Ruane L; Martin P; Prasad S; Lancini D; Cullen L
    Acad Emerg Med; 2017 Mar; 24(3):344-352. PubMed ID: 27797440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey.
    Yao H; Cottin Y; Chagué F; Maza M; Bichat F; Zeller M; Putot A
    Am Heart J; 2023 Dec; 266():86-97. PubMed ID: 37703947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of Type 2 Myocardial Infarction and Readmission With Type 1 Myocardial Infarction in Hypertensive Crises (from a Nationwide Analysis).
    Maraey A; Elzanaty AM; Salem M; Khalil M; Elsharnoby H; Younes A; Elsharnouby M; Nazir S; Elgendy IY; Siragy HM
    Am J Cardiol; 2021 Dec; 161():56-62. PubMed ID: 34794619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 Myocardial Infarction: Evolving Approaches to Diagnosis and Risk-Stratification.
    Chapman AR; Sandoval Y
    Clin Chem; 2021 Jan; 67(1):61-69. PubMed ID: 33418588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic obstructive pulmonary disease and the risk for myocardial infarction by type in people with HIV.
    Crothers K; Nance RM; Whitney BM; Harding BN; Heckbert SR; Budoff MJ; Mathews WC; Bamford L; Cachay ER; Eron JJ; Napravnik S; Moore RD; Keruly JC; Willig A; Burkholder G; Feinstein MJ; Saag MS; Kitahata MM; Crane HM; Delaney JAC;
    AIDS; 2023 Apr; 37(5):745-752. PubMed ID: 36728918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction.
    Ariss RW; Elzanaty AM; Minhas AMK; Nazir S; Gul S; Patel N; Ahuja KR; Mochon A; Eltahawy EA
    Int J Cardiol; 2021 Sep; 338():24-29. PubMed ID: 34058288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction.
    Nestelberger T; Boeddinghaus J; Badertscher P; Twerenbold R; Wildi K; Breitenbücher D; Sabti Z; Puelacher C; Rubini Giménez M; Kozhuharov N; Strebel I; Sazgary L; Schneider D; Jann J; du Fay de Lavallaz J; Miró Ò; Martin-Sanchez FJ; Morawiec B; Kawecki D; Muzyk P; Keller DI; Geigy N; Osswald S; Reichlin T; Mueller C;
    J Am Coll Cardiol; 2017 Sep; 70(13):1558-1568. PubMed ID: 28935032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causes of Elevated Cardiac Troponins in the Emergency Department and Their Associated Mortality.
    Meigher S; Thode HC; Peacock WF; Bock JL; Gruberg L; Singer AJ
    Acad Emerg Med; 2016 Nov; 23(11):1267-1273. PubMed ID: 27320126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concordance and Prognostic Relevance of Angiographic and Clinical Definitions of Myocardial Infarction Type.
    Hoang TH; Lazarev PV; Maiskov VV; Merai IA; Kobalava ZD
    J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):463-472. PubMed ID: 33836638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.